Bolt Biotherapeutics, Inc. - BOLT
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$3.287M
QoQ value delta ($000)
-$980K
(-22.97%)
Implied price effect (QoQ)
+2.79%
Shares
Total shares
602,538
QoQ shares delta
-201,498
(-25.06%)
Total shares held by funds (by quarter)
Market chart (BOLT)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Sofinnova Investments, Inc. | 753 | 137,721 | 0.03% |
| Pivotal bioVenture Partners Investment Advisor LLC | 517 | 94,573 | 0.2% |
| Vivo Capital, LLC | 395 | 72,414 | 0.03% |
| Nan Fung Group Holdings Ltd | 319 | 58,347 | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 300 | 55,025 | 0.0% |
| T3 Companies, LLC | 207 | 38,000 | 0.26% |
| Board of Trustees of The Leland Stanford Junior University | 196 | 35,977 | 0.04% |
| PFIZER INC | 171 | 31,305 | 0.07% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 112 | 20,500 | 0.1% |
| GEODE CAPITAL MANAGEMENT, LLC | 103 | 18,803 | 0.0% |
| Shay Capital LLC | 83 | 15,272 | 0.01% |
| VANGUARD GROUP INC | 55 | 10,179 | 0.0% |
| BlackRock, Inc. | 53 | 9,711 | 0.0% |
| MORGAN STANLEY | 17 | 3,128 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 723 | 0.0% |
| UBS Group AG | 2 | 515 | 0.0% |
| CITIGROUP INC | 1 | 256 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 42 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 31 | 0.0% |
| BARCLAYS PLC | 0 | 6 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 10 | 0.0% |